iCAN is collaborating with startups to create opportunities for growth
iCAN is a cutting-edge precision cancer medicine and digital health initiative. Startups collaborating with iCAN get unprecedented access to Finland’s…
Genomill and Finland’s Cancer Research Flagship iCAN Partner To Improve Cancer Detection Using an Extensive Biobank Cohort
Genomill and iCAN, the Finnish national cancer research flagship project, signed a partnership aiming to improve the detection of trace…
Cancer Data Science Tenure-Track position open at Faculty of Medicine, University of Helsinki
Tenure track position in Cancer Data Science The Faculty of Medicine at the University of Helsinki has opened a tenure-track…
Ovarian cancer research brought together patients and researchers at Biomedicum
In May, the third floor of the Biomedicum was filled with excited chatter as a group of 40 researchers and…
The joint statement on RDI funding from the Academy of Finland Flagship projects
iCAN supports the joint statement on RDI funding from the Academy of Finland Flagship projects. The recent long-term funding plan…
New tool for tailoring drug treatment in ovarian cancer
*The picture above: figure shows homologous recombination repair marker, RAD51 (red), in high-grade serous ovarian cancer tumor cell nuclei (blue)….
Exciting R2B funding news
iCAN had a strong showing in Business Finland’s last Research to Business funding round. Four out of eight projects funded…
iCAN data analyst position open at HUS and bioinformatician at FIMM
HUS IT Management is looking for a data analyst acting as an expert of HUS datasets at iCAN for a…
New subprojects initiating in the iCAN Flagship Project
The iCAN Flagship Project has taken tremendous steps in 2022 with establishment of the pipeline for prospective sample collection and…
iCAN science seminar series, spring 2023
We are happy to announce that the iCAN science seminar series continues in the spring term 2023. The seminar series…
End of content
End of content